Investigating the impact of nicotine on executive functions using a novel virtual reality assessment

Addiction

Volumn 108, Issue 5, 2013, Pages 977-984

  Jansari, Ashok S ^a   Froggatt, Daniel ^a   Edginton, Trudi ^b   Dawkins, Lynne ^a  

^a UNIVERSITY OF EAST LONDON   (United Kingdom)

^b UNIVERSITY OF WESTMINSTER   (United Kingdom)

Author keywords

Abstinence. executive functions; Nicotine; Prospective memory; Smokers; Virtual reality

Indexed keywords

NICOTINE; NICOTINIC AGENT;

ADOLESCENT; ADULT; BLOOD; DRUG EFFECTS; EPISODIC MEMORY; EXECUTIVE FUNCTION; FEMALE; HUMAN; MALE; MIDDLE AGED; SMOKING; THINKING; YOUNG ADULT; ARTICLE; DRUG EFFECT;

ADOLESCENT; ADULT; EXECUTIVE FUNCTION; FEMALE; HUMANS; MALE; MEMORY, EPISODIC; MIDDLE AGED; NICOTINE; NICOTINIC AGONISTS; SMOKING; THINKING; YOUNG ADULT;

EID: 84876407542     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.12082     Document Type: Article

References (48)

1. Le Houezec J., Halliday R., Benowitz N. L., Callaway E., Naylor H., Herzig K. A low dose of subcutaneous nicotine improves information processing in non-smokers. Psychopharmacology (Berl) 1994; 114: 628-634.
2. Di Matteo V., Pierucci M., Di Giovanni G., Benigno A., Esposito E. The neurobiological bases for the pharmacotherapy of nicotine addiction. Curr Pharm Des 2007; 13: 1269-1284.
3. Dani J. A. Roles of dopamine signaling in nicotine addiction. Mol Psychiatry 2003; 8: 255-256.
4. Alcaro A., Huber R., Panksepp J. Behavioral functions of the mesolimbic dopaminergic system: an affective neuroethological perspective. Brain Res Rev 2007; 56: 283-321.
5. Janhunen S., Ahtee L. Differential nicotinic regulation of the nigrostriatal and mesolimbic dopaminergic pathways: implications for drug development. Neurosci Biobehav Rev 2007; 31: 287-314.
6. Heishman S. J., Kleykamp B. A., Singleton E. G. Meta-analysis of the acute effects of nicotine and smoking on human performance. Psychopharmacology (Berl) 2010; 4: 453-469.
7. Leventhal A. M., Waters A. J., Boyd S., Moolchan E. T., Lerman C., Pickworth W. B. Gender differences in acute tobacco withdrawal: effects on subjective, cognitive, and physiological measures. Exp Clin Psychopharmacol 2007; 15: 21-36.
8. Hendricks P. S., Ditre J. W., Drobes D. J., Brandon T. H. The early time course of smoking withdrawal effects. Psychopharmacology (Berl) 2006; 187: 385-396.
9. Russell M., Peto J., Patel U. The classification of smoking by factorial structure of motives. J R Stat Soc 1974; 137: 313-346.
10. Heishman S. J., Taylor R. C., Henningfield J. E. Nicotine and smoking: a review of effects on human performance. Exp Clin Psychopharmacol 1994; 2: 345-395.
11. Myers C. S., Taylor R. C., Moolchan E. T., Heishman S. J. Dose-related enhancement of mood and cognition in smokers administered nicotine nasal spray. Neuropsychopharmacology 2008; 33: 588-598.
12. Levin E. D., Conners C. K., Silva D., Hinton S. C., Meck W. H., March J. etal. Transdermal nicotine effects on attention. Psychopharmacology (Berl) 1998; 140: 135-141.
13. Kleykamp B. A., Jennings J. M., Blank M., Eissenberg T. The effects of nicotine on specific cognitive processes in never-smokers. Psychol Addict Behav 2005; 19: 433-438.
14. Kumari V., Gray J. A., Ffytche D. H., Mitterschiffthaler M. T., Das M., Zachariah E. etal. Cognitive effects of nicotine in humans: an fMRI study. Neuroimage 2003; 19: 1002-1013.
15. Al-Adawi S., Powell J. The influence of smoking on reward responsiveness and cognitive functions: a natural experiment. Addiction 1997; 92: 1773-1782.
16. Powell J., Dawkins L., Davis R. Smoking, reward responsiveness and response inhibition: tests of an incentive motivational model. Biol Psychiatry 2002; 51: 151-163.
17. Neumann D., Sturm A., Boyle G., Furedy J. Effects of nicotine administration via a sublingual tablet on arousal and verbal ability in non-smokers. Aust J Psychol 2010; 62: 75-81.
18. Poltavski D. V., Petros T. Effects of transdermal nicotine on attention in adult non-smokers with and without attentional deficits. Physiol Behav 2006; 87: 614-624.
19. Grant D. A., Heaton R. K., Chelune G. J., Talley J. L., Kay G. G. Wisconsin Card Sorting Test. Odessa, FL: Psychological Assessment Resources; 1993.
20. Ashendorf L., McCaffrey R. J. Exploring age-related decline on the Wisconsin Card Sorting Test. Clin Neuropsychol 2008; 22: 262-272.
21. Rhodes M. G. Age-related differences in performance on the Wisconsin Card Sorting Task: a meta-analytic review. Psychol Aging 2004; 19: 482-494.
22. Einstein G. O., McDaniel M. A. Normal aging and prospective memory. J Exp Psychol Learn Mem Cogn 1990; 16: 717-726.
23. Ellis J., Kvavilashvili L. Prospective memory in 2000: past, present, and future directions. Appl Cogn Psychol 2000; 14: S1-9.
24. Rusted J. M., Trawley S. Comparable effects of nicotine in smokers and nonsmokers on a prospective memory task. Neuropsychopharmacology 2006; 31: 1545-1549.
25. Rusted J. M., Trawley S., Heath J., Kettle G., Walker H. Nicotine improves memory for delayed intentions. Psychopharmacology (Berl) 2005; 182: 355-365.
26. Edginton T. L., Rusted J. M. The separate and combined effects of scopolamine and nicotine on retrieval-induced forgetting. Psychopharmacology (Berl) 2003; 170: 351-357.
27. Rusted J. M., Alvares T. Nicotine effects on retrieval-induced forgetting are not attributed to changes in arousal. Psychopharmacology (Berl) 2008; 196: 83-92.
28. Evans E., Drobes D. J. Nicotine self-medication of cognitive-attentional processing. Addict Biol 2008; 14: 32-42.
29. Mumenthaler M. S., Yeasavage J. A., Taylor J. L., O'Hara R., Friedman L., Lee H. etal. Psychoactive drugs and pilot performance: a comparison of nicotine, donepezil, and alcohol effects. Neuropsychopharmacology 2003; 28: 1366-1373.
30. Jansari A., Agnew R., Akesson K., Murphy L. Using virtual reality to create an ecologically-valid measure of real-world problems in patients with dysexecutive syndrome. Brain Impair 2004; 5: 96-116.
31. Montgomery C., Hatton N., Fisk J., Ogden R., Jansari A. Assessing the functional significance of ecstasy-related memory deficits using a virtual paradigm. Hum Psychopharmacol 2010; 25: 318-325.
32. Montgomery C., Ashmore K. V., Jansari A. The effects of a modest dose of alcohol on executive functioning and prospective memory. Hum Psychopharmacol 2011; 26: 208-215.
33. Montgomery C., Seddon A. L., Fisk J. E., Murphy P. N., Jansari A. Cannabis-related deficits in real-world memory. Hum Psychopharmacol 2012; 27: 217-225.
34. Miyake A., Friedman N. P., Emerson M. J., Witzki A. H., Howerter A. The unity and diversity of executive functions and their contributions to complex 'frontal lobe' tasks: a latent variable analysis. Cognit Psychol 2000; 41: 49-100.
35. Phillips S., Fox P. An investigation into the effects of nicotine gum on short-term memory. Psychopharmacology (Berl) 1998; 140: 429-433.
36. Nyberg G., Panfilov V., Sivertsson R., Wilhelmsen L. Cardiovascular effect of nicotine chewing gum in healthy non-smokers. Eur J Clin Pharmacol 1982; 23: 303-307.
37. Pickworth W. B., Herning R. I., Henningfield J. E. Electroencephalographic effects of nicotine chewing gum in humans. Pharmacol Biochem Behav 1986; 25: 879-882.
38. Hindmarch I., Kerr J. S., Sherwood N. Effects of nicotine gum on psychomotor performance in smokers and non-smokers. Psychopharmacology (Berl) 1990; 100: 535-541.
39. Benowitz N. L., Jacob P. III. Nicotine and cotinine elimination pharmacokinetics in smokers and nonsmokers. Clin Pharmacol Ther 1993; 53: 316-323.
40. Foulds J., Stapleton J., Swettenham J., Bell N., McSorley K., Russell M. Cognitive performance effects of subcutaneous nicotine in smokers and non-smokers. Psychopharmacology (Berl) 1996; 127: 31-38.
41. Rezvani A., Levin E. Cognitive effects of nicotine. Biol Psychiatry 2001; 49: 258-267.
42. Friedman N., Miyake A. The relations among inhibition and interference control functions: a latent variable analysis. J Exp Psychol Gen 2004; 133: 101-135.
43. Schachter D. L. How the Mind Forgets and Remembers. The Seven Sins of Memory. London: Souvenir Press; 2001.
44. Dawkins L., Powell J. H., West R., Powel J., Pickering A. A double-blind placebo-controlled experimental study of nicotine: II-effects on response inhibition and executive functioning. Psychopharmacology (Berl) 2007; 190: 457-467.
45. Nooyens A. C. J., van Gelder B. M., Verschuren W. M. M. Smoking and cognitive decline among middle-aged men and women: the Doetinchen Cohort Study. Am J Public Health 2008; 98: 1-7.
46. Sabia S., Marmot M., Dufouil C., Singh-Manoux A. Smoking history and cognitive function in middle age from the Whitehall II Study. Arch Intern Med 2008; 168: 1165-1173.
47. Durrazzo T., Meyerhoff D. J., Nixon S. J. Chronic cigarette smoking: implications for neurocognition and brain neurobiology. Int J Environ Res Public Health 2010; 7: 3760-3791.
48. Heffernan T. M., O'Neill T. S., Moss M. Smoking-related prospective memory deficits in a real-world task. Drug Alcohol Depend 2012; 120: 1-6.